208 / 464
208
POSTERS AND ELECTRONIC POSTERS
| Programme and Exhibition Guide
POSTERS
S. Buus (Denmark), M. Lizondo, S. Hokland, S. Rylander, E. Pedersen,
L. Bentzen, K. Tanderup
PO-0929
> CT to TRUS based Prostate HDR: what is the optimal dosimetric
margin to use?
F. Lacroix (Canada), M. Lavallée, E. Vigneault, W. Foster, A.G. Martin
PO-0930
> Clinical outcome and quality of life after MRI-guided HDR boost for
prostate cancer.
F. Lakosi (Hungary), A. Miovecz, G. Antal, J. Pall, D. Nagy, M. Csima,
J. Hadjiev, I. Repa, G. Toller
PO-0931
> Prostate-specific Antigen bounce in patients treated with 125I prostate
brachytherapy: Keep calm
A. Pires (Portugal), D. Moreira, C. Castro, A. Oliveira, J. Oliveira, L. Trigo
PO-0932
POSTER
Brachytherapy: Gynaecolgy
> Urethral dose in cervical image guided brachytherapy
K. MacLennan (UK), M. Zahra, W. Keough
PO-0933
> Brachytherapy as part of the conservative treatment for primary and
recurrent vulvar carcinoma
C. Chargari, P. Castelnau-Marchand (France), A. Escande, I. Dumas,
R. Mazeron, P. Maroun, E. Bentivegna, S. Gouy, A. Cavalcanti,
P. Morice, C. Haie-Meder
PO-0934
> Modeling to compensate for intra-fractional bladder dose variations in
gynecological brachytherapy
Z. Siavashpour (Islamic Republic of Iran), R. Jaberi, M.R. Aghamiri,
C. Kirisits
PO-0935
> Dose effects of draining rectal gas in image-guided brachytherapy for
gynecological cancer
H. Takase (Japan), N. Ii, Y. Yamao, T. Kawamura, M. Naito, Y. Watanabe,
Y. Toyomasu, A. Takada, H. Tanaka, T. Yamada, H. Maki, H. Sakuma,
Y. Nomoto
PO-0936
> HDR image-guided interstitial brachytherapy for postoperative local
recurrent uterine cancer
K. Yoshida (Japan), H. Yamazaki, T. Takenaka, T. Kotsuma, K. Masui,